BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6371386)

  • 1. Prostacyclin bioassays using inhibition of platelet aggregation and relaxation of rabbit coeliac artery.
    Fournau P; Bonnet P; Bourgue MF; Paris J
    J Pharmacol Methods; 1984 Mar; 11(1):53-60. PubMed ID: 6371386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.
    Vane JR
    Postgrad Med J; 1983 Dec; 59(698):743-58. PubMed ID: 6361717
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of MM-706, a new prostacyclin derivative.
    Ragazzi E; Chinellato A; Lille U; Lopp M; Doni MG; Fassina G
    Gen Pharmacol; 1995 Jul; 26(4):703-9. PubMed ID: 7635245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relaxing activity of iloprost and prostaglandin E2 in the isolated various smooth muscle strips of the rabbit.
    Ercan ZS; Türker RK
    Pharmacology; 1985; 31(2):61-6. PubMed ID: 2410937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
    Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
    Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation by bioassay of mixtures of prostaglandins E2 and I2.
    Lukacsko P; Roberts AM; Messina EJ; Kaley G
    Prostaglandins Med; 1980 Mar; 4(3):171-6. PubMed ID: 6994156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo.
    Morley J; Page CP; Paul W; Mongelli N; Ceserani R; Gandolfi C
    Prostaglandins Leukot Med; 1983 Aug; 11(4):391-9. PubMed ID: 6353424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostacyclin in cardiovascular diseases].
    Kishi Y; Numano F
    Kokyu To Junkan; 1985 Jul; 33(7):865-9. PubMed ID: 3903901
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
    Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
    J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoventilation and elevation of end-expiratory pressure release a substance which relaxes isolated arteries and disaggregates platelets in the presence of cyclooxygenase inhibitors.
    Herbaczynska-Cedro K; Truskolaski P; Huszczuk A; Dusting GJ
    Prostaglandins; 1981 May; 21(5):707-17. PubMed ID: 7041193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation of human isolated pulmonary arteries by prostacyclin (PGI2).
    Hadházy P; Vizi ES; Magyar K; Debreczeni LA; Hutás I
    Lung; 1983; 161(2):123-30. PubMed ID: 6341718
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG; Karim SM; Lau LC
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.